These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 35814011)

  • 21. Biocompatibility of two model elastin-like recombinamer-based hydrogels formed through physical or chemical cross-linking for various applications in tissue engineering and regenerative medicine.
    Ibáñez-Fonseca A; Ramos TL; González de Torre I; Sánchez-Abarca LI; Muntión S; Arias FJ; Del Cañizo MC; Alonso M; Sánchez-Guijo F; Rodríguez-Cabello JC
    J Tissue Eng Regen Med; 2018 Mar; 12(3):e1450-e1460. PubMed ID: 28865091
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Protein profiling and angiogenic effect of hypoxia-cultured human umbilical cord blood-derived mesenchymal stem cells in hindlimb ischemia.
    Han KH; Kim AK; Kim MH; Kim DH; Go HN; Kang D; Chang JW; Choi SW; Kang KS; Kim DI
    Tissue Cell; 2017 Dec; 49(6):680-690. PubMed ID: 28958480
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Angiogenic effects despite limited cell survival of bone marrow-derived mesenchymal stem cells under ischemia.
    Hoffmann J; Glassford AJ; Doyle TC; Robbins RC; Schrepfer S; Pelletier MP
    Thorac Cardiovasc Surg; 2010 Apr; 58(3):136-42. PubMed ID: 20379963
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tethering QK peptide to enhance angiogenesis in elastin-like recombinamer (ELR) hydrogels.
    Flora T; de Torre IG; Alonso M; Rodríguez-Cabello JC
    J Mater Sci Mater Med; 2019 Feb; 30(2):30. PubMed ID: 30762134
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Elastin-like hydrogel stimulates angiogenesis in a severe model of critical limb ischemia (CLI): An insight into the glyco-host response.
    Marsico G; Jin C; Abbah SA; Brauchle EM; Thomas D; Rebelo AL; Orbanić D; Chantepie S; Contessotto P; Papy-Garcia D; Rodriguez-Cabello C; Kilcoyne M; Schenke-Layland K; Karlsson NG; McCullagh KJA; Pandit A
    Biomaterials; 2021 Feb; 269():120641. PubMed ID: 33493768
    [TBL] [Abstract][Full Text] [Related]  

  • 26. IGF-1C domain-modified hydrogel enhances therapeutic potential of mesenchymal stem cells for hindlimb ischemia.
    Zhao N; Yue Z; Cui J; Yao Y; Song X; Cui B; Qi X; Han Z; Han ZC; Guo Z; He ZX; Li Z
    Stem Cell Res Ther; 2019 Apr; 10(1):129. PubMed ID: 31036073
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Overexpression of Gremlin1 in Mesenchymal Stem Cells Improves Hindlimb Ischemia in Mice by Enhancing Cell Survival.
    Xiang Q; Hong D; Liao Y; Cao Y; Liu M; Pang J; Zhou J; Wang G; Yang R; Wang M; Xiang AP
    J Cell Physiol; 2017 May; 232(5):996-1007. PubMed ID: 27579673
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mesenchymoangioblast-derived mesenchymal stromal cells inhibit cell damage, tissue damage and improve peripheral blood flow following hindlimb ischemic injury in mice.
    Koch JM; D'Souza SS; Schwahn DJ; Dixon I; Hacker TA
    Cytotherapy; 2016 Feb; 18(2):219-28. PubMed ID: 26740280
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human Bone Marrow Mononuclear Cells Do Not Improve Limb Perfusion in the Hindlimb Ischemia Model.
    van Rhijn-Brouwer FCC; Gremmels H; Den Ouden K; Teraa M; Fledderus JO; Verhaar MC
    Stem Cells Dev; 2022 Apr; 31(7-8):176-180. PubMed ID: 35152731
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Allogeneic Mesenchymal Stromal Cells (MSCs) are of Comparable Efficacy to Syngeneic MSCs for Therapeutic Revascularization in C57BKSdb/db Mice Despite the Induction of Alloantibody.
    Liew A; Baustian C; Thomas D; Vaughan E; Sanz-Nogués C; Creane M; Chen X; Alagesan S; Owens P; Horan J; Dockery P; Griffin MD; Duffy A; O'Brien T
    Cell Transplant; 2018 Aug; 27(8):1210-1221. PubMed ID: 30016879
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Implantation of Hypoxia-Induced Mesenchymal Stem Cell Advances Therapeutic Angiogenesis.
    Yusoff FM; Nakashima A; Kawano KI; Kajikawa M; Kishimoto S; Maruhashi T; Ishiuchi N; Abdul Wahid SFS; Higashi Y
    Stem Cells Int; 2022; 2022():6795274. PubMed ID: 35355589
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mesenchymal stem cell-based gene therapy with prostacyclin synthase enhanced neovascularization in hindlimb ischemia.
    Ishii M; Numaguchi Y; Okumura K; Kubota R; Ma X; Murakami R; Naruse K; Murohara T
    Atherosclerosis; 2009 Sep; 206(1):109-18. PubMed ID: 19344900
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Human adipose tissue-derived mesenchymal stem cells improve postnatal neovascularization in a mouse model of hindlimb ischemia.
    Moon MH; Kim SY; Kim YJ; Kim SJ; Lee JB; Bae YC; Sung SM; Jung JS
    Cell Physiol Biochem; 2006; 17(5-6):279-90. PubMed ID: 16791003
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fucoidan protects mesenchymal stem cells against oxidative stress and enhances vascular regeneration in a murine hindlimb ischemia model.
    Han YS; Lee JH; Jung JS; Noh H; Baek MJ; Ryu JM; Yoon YM; Han HJ; Lee SH
    Int J Cardiol; 2015 Nov; 198():187-95. PubMed ID: 26163916
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cord Lining Mesenchymal Stem Cells Have a Modest Positive Effect on Angiogenesis in Hindlimb Ischemia.
    Chua K; Lim FP; Lee VKM; Phan TT; Tai BC; Tan YK
    Front Cell Dev Biol; 2020; 8():596170. PubMed ID: 33763413
    [No Abstract]   [Full Text] [Related]  

  • 36. A comparison of the reparative and angiogenic properties of mesenchymal stem cells derived from the bone marrow of BALB/c and C57/BL6 mice in a model of limb ischemia.
    Cunha FF; Martins L; Martin PK; Stilhano RS; Han SW
    Stem Cell Res Ther; 2013 Jul; 4(4):86. PubMed ID: 23890057
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An elastin-like recombinamer-based bioactive hydrogel embedded with mesenchymal stromal cells as an injectable scaffold for osteochondral repair.
    Cipriani F; Ariño Palao B; Gonzalez de Torre I; Vega Castrillo A; Aguado Hernández HJ; Alonso Rodrigo M; Àlvarez Barcia AJ; Sanchez A; García Diaz V; Lopez Peña M; Rodriguez-Cabello JC
    Regen Biomater; 2019 Dec; 6(6):335-347. PubMed ID: 31827887
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vivo efficacy of endothelial growth medium stimulated mesenchymal stem cells derived from patients with critical limb ischemia.
    Al-Rifai R; Nguyen P; Bouland N; Terryn C; Kanagaratnam L; Poitevin G; François C; Boisson-Vidal C; Sevestre MA; Tournois C
    J Transl Med; 2019 Aug; 17(1):261. PubMed ID: 31399109
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mesenchymal stem cells participate in angiogenesis and improve heart function in rat model of myocardial ischemia with reperfusion.
    Tang J; Xie Q; Pan G; Wang J; Wang M
    Eur J Cardiothorac Surg; 2006 Aug; 30(2):353-61. PubMed ID: 16829080
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tumor necrosis factor-α-activated mesenchymal stem cells promote endothelial progenitor cell homing and angiogenesis.
    Kwon YW; Heo SC; Jeong GO; Yoon JW; Mo WM; Lee MJ; Jang IH; Kwon SM; Lee JS; Kim JH
    Biochim Biophys Acta; 2013 Dec; 1832(12):2136-44. PubMed ID: 23959047
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.